Publications by authors named "Malcolm D Mason"

100Publications

The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE's "M1|RT Comparison".

Eur Urol Oncol 2020 Aug 24;3(4):412-419. Epub 2020 Jun 24.

Genito-Urinary Cancer Research Group, Division of Cancer Sciences, The University of Manchester, Manchester, UK; FASTMAN Centre of Prostate Cancer Excellence, Manchester Cancer Research Centre, Manchester, UK; Department of Surgery, The Christie NHS Foundation Trust, Manchester, UK; Department of Urology, The Salford NHS Foundation Trust, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2020.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443695PMC
August 2020

Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination.

Oncotarget 2019 Oct 29;10(59):6362-6377. Epub 2019 Oct 29.

Cardiff China Medical Research Collaborative (CCMRC), Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824871PMC
October 2019

EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).

Eur Urol 2019 Dec 3;76(6):790-813. Epub 2019 Oct 3.

Department of Urology, University Hospital Jean Monnet, St. Etienne, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.09.020DOI Listing
December 2019

Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.

Eur Urol 2019 12 23;76(6):719-728. Epub 2019 Aug 23.

The Christie and Royal Salford Hospitals, Manchester, UK; Genito Urinary Cancer Research Group and the FASTMAN Centre of Excellence, Division of Cancer Sciences, The University of Manchester, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838193062
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2019.08.006DOI Listing
December 2019

Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom.

Eur Urol 2019 08 4;76(2):228-237. Epub 2019 May 4.

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK; Leeds Institute of Data Analytics, University of Leeds, Leeds, UK; Leeds Teaching Hospitals NHS Trust, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.04.018DOI Listing
August 2019

Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment.

Anticancer Res 2017 08;37(8):4255-4268

Cardiff China Medical Research Collaborative (CCMRC), Cardiff University School of Medicine, Cardiff, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11818DOI Listing
August 2017

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

N Engl J Med 2017 07 3;377(4):338-351. Epub 2017 Jun 3.

From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1702900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533216PMC
July 2017

Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.

J Clin Oncol 2017 May 13;35(14):1530-1541. Epub 2017 Mar 13.

Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital; Jim Barber, Velindre Cancer Centre, Cardiff; Noel W. Clarke, The Christie and Salford Royal NHS Foundation Trusts; John Logue, Christie Hospital, Manchester; Nicholas D. James, Institute of Cancer and Genomic Sciences; Emilio Porfiri, The Medical School, University of Birmingham; Nicholas D. James, Queen Elizabeth Hospital; Emilio Porfiri, University Hospitals Birmingham NHS Foundation Trust, Birmingham; David P. Dearnaley, Gerhardt Attard, and Christopher C. Parker, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Melissa R. Spears, Alastair W.S. Ritchie, Francesca Schiavone, David Matheson, Robin Millman, Clare Gilson, Mahesh K.B. Parmar, and Matthew R. Sydes, MRC Clinical Trials Unit at UCL, London; William Cross, Leeds Teaching Hospitals NHS Trust, Leeds; Rob J. Jones and J. Martin Russell, University of Glasgow; Rob J. Jones and Jan Wallace, Beatson West of Scotland Cancer Centre, Glasgow; Azman Ibrahim, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral; Anna Lydon, Torbay District Hospital, Torquay; Ashok D. Nikapota, Sussex Cancer Centre, Brighton; Ashok D. Nikapota, Worthing Hospital, Worthing; Joe M. O'Sullivan, Centre for Cancer Research and Cell Biology, Queen's University, Belfast; Andrew Protheroe, Churchill Hospital, Oxford; Narayanan Nair Srihari, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury; David Tsang, Southend Hospital, Southend-on-Sea; David Tsang, Basildon Hospital, Basildon; John Wagstaff, The South West Wales Cancer Institute; John Wagstaff, Swansea University College of Medicine, Swansea; Catherine Walmsley, Royal Preston Hospital, Preston, United Kingdom; George N. Thalmann, University Hospital; Estelle Cassoly, SAKK Coordinating Center, Berne; and Cyrill A. Rentsch, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.0677DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455701PMC
May 2017

STAMPEDE trial and patients with non-metastatic prostate cancer - Authors' reply.

Lancet 2016 Jul;388(10041):235-6

Medical Research Council, Clinical Trials Unit, University College London, London WC2B 6NH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)31041-8DOI Listing
July 2016

Targeting of Receptor Activator of Nuclear Kappa B (RANK) in PC-3 Cells Increases Cell Proliferation and Matrix Adhesion In Vitro.

Anticancer Res 2016 Mar;36(3):1127-34

Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff, U.K.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/36/3/1127.full.pdf
Web Search
March 2016

Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes.

Oncotarget 2016 Apr;7(15):20124-39

Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.7716DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991442PMC
April 2016

Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro.

Int J Oncol 2016 Mar 15;48(3):919-28. Epub 2016 Jan 15.

Cardiff China Medical Research Collaborative, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2016.3339DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750544PMC
March 2016

Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis.

Oncol Lett 2015 Sep 6;10(3):1240-1250. Epub 2015 Jul 6.

Cardiff University-Peking University Cancer Institute, Cardiff University School of Medicine, Cardiff CF14 4XN, UK ; Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Cardiff CF14 4XN, UK ; Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2015.3459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533180PMC
September 2015

EPLIN: a fundamental actin regulator in cancer metastasis?

Cancer Metastasis Rev 2015 Dec;34(4):753-64

Cardiff China Medical Research Collaborative (CCMRC), Cardiff University School of Medicine, Henry Wellcome Building, Heath Park, Cardiff, CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-015-9595-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661189PMC
December 2015

YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells.

J Transl Med 2015 Aug 27;13:280. Epub 2015 Aug 27.

Cardiff University-Peking University Cancer Institute, Cardiff University School of Medicine, Henry Wellcome Building, Heath Park, Cardiff, CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-015-0639-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551384PMC
August 2015

Cardiovascular effects of hormone therapy for prostate cancer.

Drug Healthc Patient Saf 2015 23;7:129-38. Epub 2015 Jul 23.

Velindre Hospital, Whitchurch, Cardiff University, Heath Park, Cardiff, UK ; School of Medicine, Cardiff University, Heath Park, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DHPS.S50549DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516188PMC
August 2015

Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial.

J Clin Oncol 2015 Jul 26;33(19):2151-7. Epub 2015 May 26.

Michael Brundage, Queen's Cancer Research Institute and Cancer Centre of Southeastern Ontario; Wendy R. Parulekar and Bingshu E. Chen, NCIC Clinical Trials Group, Queen's University, Kingston; Padraig Warde and Andrea Bezjak, Princess Margaret Cancer Center, Toronto, Ontario; Matthew Parliament, Cross Cancer Institute, Edmonton, Alberta; Jean-Paul Bahary, Centre Hospitalier de l'Université de Montréal-Hôpital Notre-Dame, Montreal, Quebec, Canada; Matthew R. Sydes, Mahesh K.B. Parmar, and Karen Sanders, Medical Research Council Clinical Trials Unit, University College London, London; Richard Cowan, Christie Hospital and University of Manchester, Manchester; Peter Kirkbride, Clatterbridge Cancer Centre, National Health Service Foundation Trust, Wirral; Clare Moynihan, Institute of Cancer Research, Sutton; and Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital, Cardiff, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.8724DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477787PMC
July 2015

Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14 PD-L1 phenotype in prostate cancer.

Oncoimmunology 2014 Oct 13;3(9):e955331. Epub 2014 Dec 13.

Institute of Cancer and Genetics; School of Medicine ; Cardiff University ; Whitchurch, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/21624011.2014.955331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292218PMC
October 2014

Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer.

J Clin Oncol 2015 Jul 17;33(19):2143-50. Epub 2015 Feb 17.

Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital; James B.P. Barber, Velindre Hospital, Cardiff; Matthew R. Sydes, Mahesh K.B. Parmar, Gordana Jovic, Medical Research Council Clinical Trials Unit at University College London, London; Peter Kirkbride, The Clatterbridge Cancer Centre National Health Service Foundation Trust, Wirral; Richard Cowan, Christie Hospital, University of Manchester, Manchester; John Anderson, Sheffield Teaching Hospitals, National Health Service Foundation Trust, Sheffield; John Hetherington, Castle Hill Hospital, Hull; Salah El-Sharkawi, South West Wales Cancer Centre, Swansea; P.D. John Hardman, The James Cook University Hospital, Middlesbrough, United Kingdom; Wendy R. Parulekar, Andrea Hiltz, and Bingshu E. Chen, NCIC Clinical Trials Group, Queen's University; Michael Brundage, Cancer Centre of Southeastern Ontario, Kingston; Mary Gospodarowicz and Padraig Warde, University of Toronto, Princess Margaret Cancer Centre; Charles Hayter, University of Toronto, Carlo Fidani Peel Regional Cancer Center, Toronto, Ontario; Edmund C. Kostashuk, Fraser Valley Cancer Centre, Surrey; Michael McKenzie, Vancouver Cancer Centre, Vancouver, British Columbia; Jinka Sathya, Memorial University of Newfoundland, St Johns, Newfoundland and Labrador, Canada; Luis Souhami, McGill University, Montreal, Quebec, Canada; and Gregory Swanson, University of Texas Health Science Center, San Antonio, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.7510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477786PMC
July 2015

Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91.

Cancer Immunol Res 2015 Jun 12;3(6):678-88. Epub 2015 Feb 12.

Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0079DOI Listing
June 2015

Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts.

Oncotarget 2015 Jan;6(2):715-31

Institute of Cancer and Genetics, School of Medicine, Cardiff University, Velindre Cancer Centre, Whitchurch, Cardiff, United Kingdom, CF14 2TL.Cardiff Institute for Tissue Engineering and Repair, Cardiff University.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359250PMC
http://dx.doi.org/10.18632/oncotarget.2711DOI Listing
January 2015

Implication of metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R in colorectal cancer.

BMC Cancer 2014 Sep 27;14:723. Epub 2014 Sep 27.

Cardiff University-Peking University Joint Oncology Institute, Metastasis & Angiogenesis Research Group, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-723DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190326PMC
September 2014

Therapeutic potential of capillary morphogenesis gene 2 extracellular vWA domain in tumour‑related angiogenesis.

Int J Oncol 2014 Oct 3;45(4):1565-73. Epub 2014 Jul 3.

Metastasis and Angiogenesis Research Group, Cardiff University-Peking University Cancer Institute, Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2014.2533DOI Listing
October 2014

Tumour angiogenesis and repulsive guidance molecule b: a role in HGF- and BMP-7-mediated angiogenesis.

Int J Oncol 2014 Sep 20;45(3):1304-12. Epub 2014 Jun 20.

Cardiff University-Peking University Cancer Institute, Cardiff University School of Medicine, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2014.2508DOI Listing
September 2014

Capillary morphogenesis gene 2 regulates adhesion and invasiveness of prostate cancer cells.

Oncol Lett 2014 Jun 4;7(6):2149-2153. Epub 2014 Apr 4.

Metastasis and Angiogenesis Research Group, Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2014.2038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049711PMC
June 2014

HGF and the regulation of tight junctions in human prostate cancer cells.

Oncol Rep 2014 Jul 26;32(1):213-24. Epub 2014 May 26.

Cardiff University-Peking University Cancer Research Institute, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2014.3219DOI Listing
July 2014

Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis.

J Cancer Res Clin Oncol 2014 Jun 26;140(6):957-67. Epub 2014 Mar 26.

Metastasis and Angiogenesis Research Group, Institute of Cancer and Genetics, Cardiff University School of Medicine, GF46, Henry Wellcome Building, Heath Park, Cardiff, CF14 4XN, UK,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-014-1650-2DOI Listing
June 2014

Enhancement of T cell responses as a result of synergy between lower doses of radiation and T cell stimulation.

J Immunol 2014 Apr 5;192(7):3101-10. Epub 2014 Mar 5.

Institute of Cancer and Genetics, School of Medicine, Cardiff University, Whitchurch, Cardiff CF14 2TL, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1302736DOI Listing
April 2014

Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan™) platform.

Mol Cell Proteomics 2014 Apr 6;13(4):1050-64. Epub 2014 Feb 6.

Institute of Cancer and Genetics, School of Medicine, Cardiff University, Velindre Cancer Centre, Whitchurch, Cardiff CF14 2TL, United Kingdom;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.M113.032136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977183PMC
April 2014

Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain.

J Transl Med 2013 Oct 25;11:269. Epub 2013 Oct 25.

Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-11-269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874635PMC
October 2013

Receptor-like protein tyrosine phosphatase κ negatively regulates the apoptosis of prostate cancer cells via the JNK pathway.

Int J Oncol 2013 Nov 29;43(5):1560-8. Epub 2013 Aug 29.

Metastasis and Angiogenesis Research Group, Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2013.2082DOI Listing
November 2013

The Kiss-1/Kiss-1R complex as a negative regulator of cell motility and cancer metastasis (Review).

Int J Mol Med 2013 Oct 21;32(4):747-54. Epub 2013 Aug 21.

Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijmm.2013.1472DOI Listing
October 2013

Antitumour effects of Yangzheng Xiaoji in human osteosarcoma: the pivotal role of focal adhesion kinase signalling.

Oncol Rep 2013 Sep 3;30(3):1405-13. Epub 2013 Jul 3.

Cardiff University-Peking University School of Oncology Joint Institute, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2013.2586DOI Listing
September 2013

Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer.

J Cancer Res Clin Oncol 2013 Jul 4;139(7):1129-39. Epub 2013 Apr 4.

Metastasis and Angiogenesis Research Group, Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-013-1421-5DOI Listing
July 2013

Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.

Anticancer Res 2013 Jan;33(1):199-206

Metastasis and Angiogenesis Research Group, Department of Surgery, Cardiff University School of Medicine, Cardiff, CF14 4XN, U.K.

View Article

Download full-text PDF

Source
January 2013

Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo.

Mol Cell Biochem 2013 Mar 13;375(1-2):207-17. Epub 2012 Dec 13.

Metastasis & Angiogenesis Research Group, Institute of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11010-012-1544-zDOI Listing
March 2013

Protein tyrosine phosphatase µ (PTP µ or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis.

PLoS One 2012 20;7(11):e50183. Epub 2012 Nov 20.

Metastasis & Angiogenesis Research Group, Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, United Kingdom.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0050183PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502354PMC
May 2013

Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathway.

Int J Oncol 2012 Nov 11;41(5):1635-42. Epub 2012 Sep 11.

Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2012.1627DOI Listing
November 2012

The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin.

Oncol Rep 2012 Oct 2;28(4):1491-7. Epub 2012 Aug 2.

Metastasis and Angiogenesis Research Group, Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2012.1945DOI Listing
October 2012

Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells.

Urol Oncol 2013 Nov 12;31(8):1576-83. Epub 2012 Jun 12.

Metastasis and Angiogenesis Research Group, Institute of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2012.05.006DOI Listing
November 2013

Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer.

Support Care Cancer 2013 Jan 28;21(1):173-81. Epub 2012 May 28.

School of Healthcare Studies, Cardiff University, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-012-1508-6DOI Listing
January 2013

Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma.

Lung Cancer 2012 Aug 10;77(2):312-8. Epub 2012 Apr 10.

Department of Oncology, School of Medicine, Cardiff University, Velindre Cancer Centre, Velindre Road, Whitchurch, Cardiff CF14 2TL, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016950021200119
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2012.03.008DOI Listing
August 2012

Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review.

BJU Int 2012 Feb;109(4):496-505

Cochrane Prostatic Diseases and Urological Cancers Unit, Research Department, Velindre NHS Trust, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2011.10880.xDOI Listing
February 2012

The role of surgery in high-risk localised prostate cancer.

BJU Int 2012 Mar 27;109(5):648-58. Epub 2011 Sep 27.

Translational Prostate Cancer Group, Department of Oncology, Hutchison/MRC research centre, University of Cambridge, Cambridge, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1464-410X.2011.10596.x
Publisher Site
http://dx.doi.org/10.1111/j.1464-410X.2011.10596.xDOI Listing
March 2012

Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma.

BJU Int 2011 Jul;108(2):168-79

Cochrane Urological Cancers Unit, Velindre NHS Trust Cardiff, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2011.10341.xDOI Listing
July 2011

A novel tumor antigen derived from enhanced degradation of bax protein in human cancers.

Cancer Res 2011 Aug 22;71(16):5435-44. Epub 2011 Jun 22.

Departments of Infection, Immunity and Biochemistry, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-0393DOI Listing
August 2011

Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.

J Immunol 2011 Jul 15;187(2):676-83. Epub 2011 Jun 15.

Department of Pharmacology, Radiology and Oncology, School of Medicine, Cardiff University, Velindre Cancer Centre, Whitchurch, Cardiff CF14 2TL, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1003884DOI Listing
July 2011

EPLIN is a negative regulator of prostate cancer growth and invasion.

J Urol 2011 Jul 20;186(1):295-301. Epub 2011 May 20.

Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Cardiff, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2011.03.038DOI Listing
July 2011

The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literature.

Eur Urol 2011 Aug 29;60(2):270-8. Epub 2011 Apr 29.

Veterans Affairs Medical Centre and the Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2011.04.032DOI Listing
August 2011

Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.

J Transl Med 2011 Apr 28;9:49. Epub 2011 Apr 28.

Department of Pathology, University of Arizona College of Medicine, Arizona Cancer Center and BIO5 Institute, Tucson, Arizona, AZ 85724-5043 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-9-49DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113954PMC
April 2011

HAVcR-1 reduces the integrity of human endothelial tight junctions.

Anticancer Res 2011 Feb;31(2):467-73

Metastasis & Angiogenesis Research Group, Department of Surgery, Cardiff School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
February 2011

Tight junctions in cancer metastasis.

Front Biosci (Landmark Ed) 2011 Jan 1;16:898-936. Epub 2011 Jan 1.

Metastasis and Angiogenesis Research Group, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/3726DOI Listing
January 2011

Bone morphogenetic protein and bone metastasis, implication and therapeutic potential.

Front Biosci (Landmark Ed) 2011 Jan 1;16:865-97. Epub 2011 Jan 1.

Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/3725DOI Listing
January 2011

Type II transmembrane serine protease (TTSP) deregulation in cancer.

Front Biosci (Landmark Ed) 2011 Jan 1;16:539-52. Epub 2011 Jan 1.

Metastasis and Angiogenesis Research Group, Department of Surgery, Cardiff University School of Medicine, Cardiff, UK, CF14 4XN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/3704DOI Listing
January 2011

Cancer exosomes trigger fibroblast to myofibroblast differentiation.

Cancer Res 2010 Dec 23;70(23):9621-30. Epub 2010 Nov 23.

Department of Pharmacology, Oncology & Radiation, School of Medicine, Cardiff University, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-1722DOI Listing
December 2010

The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis.

Angiogenesis 2010 Dec 17;13(4):317-26. Epub 2010 Sep 17.

Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10456-010-9188-7DOI Listing
December 2010

The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy.

J Exp Ther Oncol 2010 ;8(3):203-10

School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom.

View Article

Download full-text PDF

Source
September 2010

The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells.

Int J Oncol 2010 Aug;37(2):413-8

Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo_00000689DOI Listing
August 2010

Resistance of CD45RA- T cells to apoptosis and functional impairment, and activation of tumor-antigen specific T cells during radiation therapy of prostate cancer.

J Immunol 2010 Jul 14;185(2):1330-9. Epub 2010 Jun 14.

Department of Pharmacology, Radiology and Oncology, School of Medicine, Cardiff University, Cancer Research Wales Research Laboratories, Velindre Cancer Centre, Whitchurch, Cardiff, CF14 2TL, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1000488DOI Listing
July 2010

IL-17B Can Impact on Endothelial Cellular Traits Linked to Tumour Angiogenesis.

J Oncol 2010 6;2010:817375. Epub 2010 May 6.

Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2010/817375DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866247PMC
July 2011

Proteomics analysis of bladder cancer exosomes.

Mol Cell Proteomics 2010 Jun 11;9(6):1324-38. Epub 2010 Mar 11.

Section of Oncology and Palliative Medicine, Department of Pharmacology, Oncology and Radiology, School of Medicine, Cardiff University, Velindre Cancer Centre, Whitchurch, Cardiff CF14 2TL, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.M000063-MCP201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877990PMC
June 2010

Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses.

Cancer Treat Rev 2010 May 15;36(3):195-205. Epub 2010 Jan 15.

Cochrane Unit, Research Department, Velindre NHS Trust, Whitchurch, Cardiff, Wales CF14 2TL, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2009.12.005DOI Listing
May 2010

The type II transmembrane serine protease, matriptase-2: Possible links to cancer?

Anticancer Agents Med Chem 2010 Jan;10(1):64-9

Cardiff University School of Medicine, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1871520611009010064DOI Listing
January 2010

Can urinary exosomes act as treatment response markers in prostate cancer?

J Transl Med 2009 Jan 12;7. Epub 2009 Jan 12.

Section of Oncology & Palliative Medicine, School of Medicine, Cardiff University, Velindre Cancer Centre, Whitchurch, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-7-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631476PMC
January 2009

The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway.

Microvasc Res 2009 Mar 15;77(2):150-7. Epub 2008 Oct 15.

Metastasis & Angiogenesis Research Group, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mvr.2008.09.010DOI Listing
March 2009